AUS
NZ
UK
CA
USA
IND
Highlights
- Advanced Medical Solutions Group recorded 8.2% YoY growth in its top-line business in H1 FY23.
- Interim dividend of the firm has increased by around 9.4% YoY in the reporting period.
- At present, AMS is analysing multiple potential commercialisation strategies in the United States for LiquiBandFix8®.
FTSE AIM UK 50 Index-listed company Advanced Medical Solutions Group PLC (LSE:AMS) specialises in designing, production, and development of surgical equipment and advanced wound care products. In a recent announcement, AMS revealed that it’s US LiquiBand® route-to-market strategy is now 100% functional following the signing of three hospital distribution agreements.
In the first half of the year 2023, the group has recorded 8.2% year-on-year growth in its top-line business. However, the net cash has reduced by 8.2% YoY in H1 FY23.
Interim dividend of the firm has increased by around 9.4% YoY in the reporting period. AMS had paid an interim dividend of 0.70 pence per share in October 2023, with the ex-dividend date of 28 September 2023.
The company expects the launch of LiquiBand® in the United States by the end of 2023 to bring in huge opportunity in terms of reach to a massive addressable market of over USD 200 million.
In the quarter, the company showed impressive progress in regulatory and clinical developments required for building the next generation of innovative products. At present, AMS is analysing multiple potential commercialisation strategies in the United States for LiquiBandFix8®. Overall, Advanced Medical Solutions Group continues to enhance its portfolio and expand into new markets to ensure long-term growth.
Top 10 Shareholders:
Around 49.81% of the total shareholdings in the company is held by its top ten shareholders. While Octopus Investments Limited is the biggest shareholder with the maximum number of shares of approximately 12.61%, Canaccord Genuity Wealth Management is the second-biggest shareholder with nearly 7.02% shareholding in the firm.
Stock Price Performance and Technical Summary:
AMS stock price has increased by 1.42% in the last one month. It has dropped by approximately 12.35% over the last six months. The stock’s 52-week low and high price stand at GBX 165.60 and GBX 289.50, respectively.
Note 1: Past performance is not a reliable indicator of future performance.
Note 2: The reference data for all price data, currency, technical indicators, support, and resistance levels is 13 December 2023. The reference data in this report has been partly sourced from EODHD/Others.
